Literature DB >> 11431917

[Pulmonary Nocardia otitidis-caviarum infection in a patient with Cushing's disease].

A Sudou1, T Hashimoto, H Nakamura, H Yagyuu, G Sarashina, E Hatao, F Tuchida, H Adachi, K Kishi, T Matuoka.   

Abstract

While Nocardial infections are being diagnosed with increasing frequency, infection with Nocardia otitidiscaviarum remains relatively uncommon. We report a case of pulmonary Nocardia otitidis-caviarum infection in a 35-year-old man with Cushing's disease. This work describes the first case of nocardiosis in Japan caused by Nocardia otitidis-caviarum in Cushing's disease. The patient was admitted to our department because of edema. A diagnosis of Cushing's disease was made on the basis of elevated serum levels of cortisol and adrenocorticotropic hormone (ACTH) and pituitary adenoma was found in a cranial CT scan. One month after admission, chest radiographs showed a large bilateral mass on the lung fields. Nocardia otitidis-caviarum was isolated from the sputum. The patient responded poorly to intravenous PAPM/BP, but later improved after treatment with trimethoprim-sulfamethoxazole, but he died of heart failure and respiratory failure after the initiation of this therapy. This case demonstrated that nocardiosis must be considered in differential diagnosis as an opportunistic infection.

Entities:  

Mesh:

Year:  2001        PMID: 11431917

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  2 in total

Review 1.  A fatal case of disseminated nocardiosis due to Nocardia otitidiscaviarum resistant to trimethoprim-sulfamethoxazole: case report and literature review.

Authors:  Mazin Barry; Shahad AlShehri; Ahlam Alguhani; Mohammad Barry; Ali Alhijji; Khalifa Binkhamis; Fahad Al-Majid; Fatimah S Al-Shahrani; Taim Muayqil
Journal:  Ann Clin Microbiol Antimicrob       Date:  2022-05-16       Impact factor: 6.781

2.  Case report: nocardia infection associated with ectopic cushings.

Authors:  Azra Rizwan; Aqiba Sarfaraz; Abdul Jabbar; Jaweed Akhter; Najmul Islam
Journal:  BMC Endocr Disord       Date:  2014-06-20       Impact factor: 2.763

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.